US Stock MarketDetailed Quotes

NVIVQ INVIVO THERAPEUTICS HOLDING CORP

Watchlist
  • 0.370
  • 0.0000.00%
15min DelayClose Jul 15 16:00 ET
1.15MMarket Cap-0.11P/E (TTM)

INVIVO THERAPEUTICS HOLDING CORP Key Stats

Earnings

Revenue Breakdown

Financial Indicators

Income Statement

Balance Sheet

Cash Flow

Quarterly+Annual
YOY yoy
Hide blank lines yoy
(Q3)Sep 30, 2023
(Q2)Jun 30, 2023
(Q1)Mar 31, 2023
(FY)Dec 31, 2022
(Q4)Dec 31, 2022
(Q3)Sep 30, 2022
(Q2)Jun 30, 2022
(Q1)Mar 31, 2022
(FY)Dec 31, 2021
(Q4)Dec 31, 2021
Operating Cash Flow (Indirect Method)
Cash flow from continuing operating activities
3.71%-2.28M
-17.16%-2.45M
16.32%-3.2M
-18.39%-10.48M
-8.95%-2.19M
-24.41%-2.37M
-22.84%-2.09M
-18.36%-3.83M
7.13%-8.85M
-4.63%-2.01M
Net income from continuing operations
2.11%-2.7M
28.76%-1.94M
12.17%-2.33M
-6.01%-10.49M
18.92%-2.36M
-12.40%-2.76M
-17.76%-2.72M
-19.43%-2.66M
-9.05%-9.9M
-32.85%-2.91M
Operating gains losses
--33K
--30K
--53K
----
----
----
----
----
----
----
Depreciation and amortization
-34.55%72K
1.83%111K
10.19%119K
19.62%445K
20.41%118K
15.79%110K
21.11%109K
21.35%108K
13.07%372K
13.95%98K
Change In working capital
62.18%386K
-238.32%-693K
17.34%-1.11M
-268.36%-596K
-99.58%3K
-34.97%238K
19.00%501K
-16.05%-1.34M
135.26%354K
414.29%720K
-Change in prepaid assets
236.32%787K
-201.86%-274K
70.72%-207K
-132.69%-17K
4.47%187K
-2.90%234K
22.27%269K
-20.24%-707K
271.43%52K
49.17%179K
-Change in payables and accrued expense
-456.38%-335K
-199.69%-321K
-47.61%-803K
-134.17%-219K
-114.42%-91K
-56.68%94K
15.41%322K
-11.93%-544K
188.54%641K
550.52%631K
-Change in other current liabilities
26.67%-66K
-8.89%-98K
-10.34%-96K
-6.19%-360K
-3.33%-93K
2.17%-90K
-15.38%-90K
-10.13%-87K
-15.31%-339K
-16.88%-90K
Cash from discontinued investing activities
Operating cash flow
3.71%-2.28M
-17.16%-2.45M
16.32%-3.2M
-18.39%-10.48M
-8.95%-2.19M
-24.41%-2.37M
-22.84%-2.09M
-18.36%-3.83M
7.13%-8.85M
-4.63%-2.01M
Investing cash flow
Cash flow from continuing investing activities
170.49%43K
139.29%22K
107.69%2K
-107.79%-160K
71.19%-17K
-238.89%-61K
-56K
-26K
-87.80%-77K
-353.85%-59K
Net PPE purchase and sale
170.49%43K
139.29%22K
107.69%2K
-107.79%-160K
71.19%-17K
-238.89%-61K
---56K
---26K
-87.80%-77K
-353.85%-59K
Cash from discontinued investing activities
Investing cash flow
170.49%43K
139.29%22K
107.69%2K
-107.79%-160K
71.19%-17K
-238.89%-61K
---56K
---26K
-87.80%-77K
-353.85%-59K
Financing cash flow
Cash flow from continuing financing activities
-6.43%7.96M
-62.12%8.51M
0
Net common stock issuance
----
----
----
--7.96M
----
----
----
----
--0
----
Proceeds from stock option exercised by employees
----
----
----
--0
----
----
----
----
2,380.76%8.51M
--0
Cash from discontinued financing activities
Financing cash flow
----
----
----
-6.43%7.96M
----
----
----
----
-62.12%8.51M
--0
Net cash flow
Beginning cash position
-17.51%10.87M
-13.23%13.3M
-13.97%16.5M
-2.15%19.18M
-49.43%10.75M
-43.13%13.18M
-38.39%15.33M
-2.15%19.18M
191.89%19.6M
165.27%21.25M
Current changes in cash
7.90%-2.24M
-13.08%-2.43M
16.94%-3.2M
-535.07%-2.68M
377.97%5.75M
-26.42%-2.43M
-26.13%-2.15M
-173.09%-3.86M
-103.27%-422K
-117.86%-2.07M
End cash Position
-19.69%8.63M
-17.51%10.87M
-13.23%13.3M
-13.97%16.5M
-13.97%16.5M
-49.43%10.75M
-43.13%13.18M
-38.39%15.33M
-2.15%19.18M
-2.15%19.18M
Free cash flow
6.13%-2.28M
-14.43%-2.46M
16.34%-3.23M
-19.16%-10.64M
-6.67%-2.21M
-26.42%-2.43M
-26.13%-2.15M
-19.17%-3.86M
6.73%-8.93M
-6.98%-2.07M
Currency Unit
USD
USD
USD
USD
USD
USD
USD
USD
USD
USD
Audit Opinions
--
--
--
Unqualified Opinion with Explanatory Notes
--
--
--
--
Unqualified Opinion
--
(Q3)Sep 30, 2023(Q2)Jun 30, 2023(Q1)Mar 31, 2023(FY)Dec 31, 2022(Q4)Dec 31, 2022(Q3)Sep 30, 2022(Q2)Jun 30, 2022(Q1)Mar 31, 2022(FY)Dec 31, 2021(Q4)Dec 31, 2021
Operating Cash Flow (Indirect Method)
Cash flow from continuing operating activities 3.71%-2.28M-17.16%-2.45M16.32%-3.2M-18.39%-10.48M-8.95%-2.19M-24.41%-2.37M-22.84%-2.09M-18.36%-3.83M7.13%-8.85M-4.63%-2.01M
Net income from continuing operations 2.11%-2.7M28.76%-1.94M12.17%-2.33M-6.01%-10.49M18.92%-2.36M-12.40%-2.76M-17.76%-2.72M-19.43%-2.66M-9.05%-9.9M-32.85%-2.91M
Operating gains losses --33K--30K--53K----------------------------
Depreciation and amortization -34.55%72K1.83%111K10.19%119K19.62%445K20.41%118K15.79%110K21.11%109K21.35%108K13.07%372K13.95%98K
Change In working capital 62.18%386K-238.32%-693K17.34%-1.11M-268.36%-596K-99.58%3K-34.97%238K19.00%501K-16.05%-1.34M135.26%354K414.29%720K
-Change in prepaid assets 236.32%787K-201.86%-274K70.72%-207K-132.69%-17K4.47%187K-2.90%234K22.27%269K-20.24%-707K271.43%52K49.17%179K
-Change in payables and accrued expense -456.38%-335K-199.69%-321K-47.61%-803K-134.17%-219K-114.42%-91K-56.68%94K15.41%322K-11.93%-544K188.54%641K550.52%631K
-Change in other current liabilities 26.67%-66K-8.89%-98K-10.34%-96K-6.19%-360K-3.33%-93K2.17%-90K-15.38%-90K-10.13%-87K-15.31%-339K-16.88%-90K
Cash from discontinued investing activities
Operating cash flow 3.71%-2.28M-17.16%-2.45M16.32%-3.2M-18.39%-10.48M-8.95%-2.19M-24.41%-2.37M-22.84%-2.09M-18.36%-3.83M7.13%-8.85M-4.63%-2.01M
Investing cash flow
Cash flow from continuing investing activities 170.49%43K139.29%22K107.69%2K-107.79%-160K71.19%-17K-238.89%-61K-56K-26K-87.80%-77K-353.85%-59K
Net PPE purchase and sale 170.49%43K139.29%22K107.69%2K-107.79%-160K71.19%-17K-238.89%-61K---56K---26K-87.80%-77K-353.85%-59K
Cash from discontinued investing activities
Investing cash flow 170.49%43K139.29%22K107.69%2K-107.79%-160K71.19%-17K-238.89%-61K---56K---26K-87.80%-77K-353.85%-59K
Financing cash flow
Cash flow from continuing financing activities -6.43%7.96M-62.12%8.51M0
Net common stock issuance --------------7.96M------------------0----
Proceeds from stock option exercised by employees --------------0----------------2,380.76%8.51M--0
Cash from discontinued financing activities
Financing cash flow -------------6.43%7.96M-----------------62.12%8.51M--0
Net cash flow
Beginning cash position -17.51%10.87M-13.23%13.3M-13.97%16.5M-2.15%19.18M-49.43%10.75M-43.13%13.18M-38.39%15.33M-2.15%19.18M191.89%19.6M165.27%21.25M
Current changes in cash 7.90%-2.24M-13.08%-2.43M16.94%-3.2M-535.07%-2.68M377.97%5.75M-26.42%-2.43M-26.13%-2.15M-173.09%-3.86M-103.27%-422K-117.86%-2.07M
End cash Position -19.69%8.63M-17.51%10.87M-13.23%13.3M-13.97%16.5M-13.97%16.5M-49.43%10.75M-43.13%13.18M-38.39%15.33M-2.15%19.18M-2.15%19.18M
Free cash flow 6.13%-2.28M-14.43%-2.46M16.34%-3.23M-19.16%-10.64M-6.67%-2.21M-26.42%-2.43M-26.13%-2.15M-19.17%-3.86M6.73%-8.93M-6.98%-2.07M
Currency Unit USDUSDUSDUSDUSDUSDUSDUSDUSDUSD
Audit Opinions ------Unqualified Opinion with Explanatory Notes--------Unqualified Opinion--
Heat List
US
Overall
Symbol
Price
% Chg

No Data